Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Follicular Lymphoma, Indolent Lymphoma

Nathan Fowler

MD

🏢AstraZeneca (formerly MD Anderson)🌐USA

Medical Oncologist

46
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Nathan Fowler is an expert in follicular and indolent lymphoma who has contributed to establishing new treatment standards in this disease including obinutuzumab-based regimens and novel targeted agents. He led pivotal trials of PI3K inhibitors and CD20-targeted combination therapies in follicular lymphoma, and has been involved in defining treatment algorithms for this chronic disease.

Share:

🧪Research Fields 研究领域

follicular lymphoma
obinutuzumab
PI3K inhibitors
anti-CD20 therapy
indolent lymphoma treatment

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-02-01 | All information from publicly available academic sources

关注 Nathan Fowler 的研究动态

Follow Nathan Fowler's research updates

留下邮箱,当我们发布与 Nathan Fowler(AstraZeneca (formerly MD Anderson))相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment